Ampio Pharmaceuticals AMPE Stock
0.62 USD
{{ price }}
-12.915109%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NYSE American
Market Cap
703.92K USD
LOW - HIGH [24H]
0.62
-
0.7 USD
VOLUME [24H]
52.79K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-10.66 USD
Ampio Pharmaceuticals Price Chart
Ampio Pharmaceuticals AMPE Financial and Trading Overview
| Ampio Pharmaceuticals stock price | 0.62 USD |
| Previous Close | 0.25 USD |
| Open | 0.23 USD |
| Bid | 0.22 USD x 1000 |
| Ask | 0.28 USD x 3000 |
| Day's Range | 0.23 - 0.27 USD |
| 52 Week Range | 0.18 - 3.15 USD |
| Volume | 32.27K USD |
| Avg. Volume | 388.65K USD |
| Market Cap | 3.94M USD |
| Beta (5Y Monthly) | 1.818661 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.66 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AMPE Valuation Measures
| Enterprise Value | -5909128 USD |
| Trailing P/E | N/A |
| Forward P/E | -2.9022222 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.50038314 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.351 |
Trading Information
Ampio Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.818661 |
| 52-Week Change | -89.16% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.15 USD |
| 52 Week Low | 0.18 USD |
| 50-Day Moving Average | 0.25 USD |
| 200-Day Moving Average | 0.42 USD |
AMPE Share Statistics
| Avg. Volume (3 month) | 388.65K USD |
| Avg. Daily Volume (10-Days) | 182.22K USD |
| Shares Outstanding | 15.1M |
| Float | 13.86M |
| Short Ratio | 0.64 |
| % Held by Insiders | 7.49% |
| % Held by Institutions | 2.80% |
| Shares Short | 446.88K |
| Short % of Float | 2.95% |
| Short % of Shares Outstanding | 2.95% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -50.99% |
| Return on Equity (ttm) | -97.43% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -16835000 USD |
| Net Income Avi to Common (ttm) | -14679000 USD |
| Diluted EPS (ttm) | -1.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.39M USD |
| Total Cash Per Share (mrq) | 0.69 USD |
| Total Debt (mrq) | 532K USD |
| Total Debt/Equity (mrq) | 6.75 USD |
| Current Ratio (mrq) | 4.018 |
| Book Value Per Share (mrq) | 0.522 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18485000 USD |
| Levered Free Cash Flow (ttm) | -12411875 USD |
Profile of Ampio Pharmaceuticals
| Country | United States |
| State | CO |
| City | Englewood |
| Address | 373 Inverness Parkway |
| ZIP | 80112 |
| Phone | 720 437 6500 |
| Website | https://ampiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.
Q&A For Ampio Pharmaceuticals Stock
What is a current AMPE stock price?
Ampio Pharmaceuticals AMPE stock price today per share is 0.62 USD.
How to purchase Ampio Pharmaceuticals stock?
You can buy AMPE shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ampio Pharmaceuticals?
The stock symbol or ticker of Ampio Pharmaceuticals is AMPE.
Which industry does the Ampio Pharmaceuticals company belong to?
The Ampio Pharmaceuticals industry is Biotechnology.
How many shares does Ampio Pharmaceuticals have in circulation?
The max supply of Ampio Pharmaceuticals shares is 1.14M.
What is Ampio Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Ampio Pharmaceuticals PE Ratio is now.
What was Ampio Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Ampio Pharmaceuticals EPS is -10.66 USD over the trailing 12 months.
Which sector does the Ampio Pharmaceuticals company belong to?
The Ampio Pharmaceuticals sector is Healthcare.